Beverly A Teicher

Title: Beverly A. Teicher: Innovator in Metabolic Disorder Treatments

Introduction

Beverly A. Teicher is a prominent inventor based in Needham, MA, known for her significant contributions to the field of metabolic disorder treatments. With a total of nine patents to her name, she has made remarkable strides in the development of innovative therapies.

Latest Patents

One of her latest patents focuses on the use of creatine analogues and creatine kinase modulators for treating or preventing various metabolic disorders. This invention relates to the application of creatine compounds, including cyclocreatine and creatine phosphate, to address conditions such as hyperglycemia, insulin-dependent diabetes mellitus, and impaired glucose tolerance. The patent outlines the use of compounds that can act as substrates or substrate analogues for the enzyme creatine kinase, as well as those that can modulate the creatine transporter. Another notable patent describes a method of enhancing the effective life of oxygen-delivery agents by administering an oxygen-enriched atmosphere to subjects who have received the oxygen-delivery agent at a predetermined time.

Career Highlights

Throughout her career, Beverly has worked with esteemed organizations, including the Dana-Farber Cancer Institute and Biopure Corporation. Her work has significantly impacted the understanding and treatment of metabolic disorders, showcasing her dedication to advancing medical science.

Collaborations

Beverly has collaborated with notable colleagues, including Carl W. Rausch and Robert E. Hopkins, 2nd. These partnerships have further enriched her research and development efforts.

Conclusion

Beverly A. Teicher's innovative work in the field of metabolic disorders has led to the development of groundbreaking therapies that hold promise for improving patient outcomes. Her contributions continue to inspire advancements in medical research and treatment methodologies.